Filing Details
- Accession Number:
- 0001104659-21-071822
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-05-25 16:31:13
- Reporting Period:
- 2021-05-21
- Accepted Time:
- 2021-05-25 16:31:13
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1640266 | Voyager Therapeutics Inc. | VYGR | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1776393 | Omar Khwaja | C/O Voyager Therapeutics, Inc., 75 Sidney Street Cambridge MA 02139 | See Remarks | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-05-21 | 3,516 | $4.03 | 120,509 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Represents shares of common stock sold, pursuant to a durable automatic sales instruction letter effecting the sell-to-cover election of the reporting person tosatisfy tax withholding obligations, in connection with the vesting of restricted stock units on May 20, 2021. The reporting person structured the durableautomatic sales instructions to constitute a "binding contract" consistent with the affirmative defense to liability under Rule 10b5-1. The sales do notrepresent a discretionary trade by the reporting person.
Billionaire Hedge Funds
